Net Cash Provided by (Used in) Operating Activities |
-28.2K |
USD |
-231% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
29K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
42M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.06K |
USD |
-50.9% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
4.97M |
USD |
+0.92% |
Dec 31, 2023 |
Q4 2023 |
Cash and Cash Equivalents, Period Increase (Decrease) |
86.3K |
USD |
|
Mar 31, 2022 |
Q1 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
4.97M |
USD |
+0.92% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Income Tax Expense (Benefit) |
45.3K |
USD |
-10.6% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
29.2M |
USD |
+0.39% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |